Denise Lockett wants to know what is the science of deaths from measles (September 3). She is angry about Big Pharma profiting from the sale of MMV vaccines.
I guess she does not have access to the internet; I only had to type "measles deaths" into Google to learn that
2,600,000 died from measles in 1980. And by 2014, global vaccination programmes had reduced the number of deaths from measles to 73,000.
However, anti-vaccination campaigns have reduced the number of children being protected, and deaths have since risen to 110,000 per year. In First World conditions, one patient in 1000 develops encephalitis that can lead to death. In Third World conditions, one measles patient in every 300 dies.
In New Zealand's 1991 measles epidemic, about 7000 cases were reported and seven people died. So far in our current epidemic there have been 975 cases of measles, with about 350 hospitalised from complications (diarrhoea, pneumonia, ear infection), and one child in intensive care with encephalitis.
Merck's 10-dose ampoule of MMV vaccine costs US$75, or $125. About 55,000 babies are born in New Zealand each year and about 18,000 are not vaccinated, saving the NZ taxpayer about $230,000, and depriving "Big Pharma" of about $60,000 in profits.
One day in a hospital bed with measles complications costs New Zealand taxpayers about $300. The complications can last for a week or more. So far, the 350 people hospitalised with measles have cost taxpayers more than $800,000.